Application Deadline: 15.07.2018
Registration Fee (50.00€)
Transition is hot topic in many aspects of different gastrointestinal disorders, however, very few evidence exist so far.
Therefore, ESPGHAN and UEG launch a joint meeting on transition of different gastrointestinal-, liver-, and panceatic disorders.
In this Master Class, new findings and important knowledge in gastrointestinal disease, such as IBD, Celiac disease, Eosinophil oesophagitis, and Chronic liver disease and Chronic pancreatitis were involved. Participants should submit (not obligated) and intersting case presentation related to the pitfalls/difficulties of transition process.
Please, participate on this unique Master Class in Budapest, be in science and enjoy the social program, as well!
Please click the below link to view a short video on the Transition Masterclass in 2018
Course Directors: Gábor Veres, Jorge Amil Dias, Heinz Hammer
• Concept of the meeting: 1.5 days, 5 sessions. In each session two pediatric and two adult GI/hep presenters discussing age specific aspects of diagnosis and treatment of their respective patient groups – four 20 minute case-based presentations and 30 minutes for interactive voting and discussion.
• Aim of the meeting: improve coordination of care on the transfer of paediatric to adult patients
• E-learning: Short, concise video presentations, 5 min. each lecture. Lecturer has to summarize his/her presentation with "take home messages". In addition, every lecture would be displayed in PDF form with questionnaires.
• What is similar and different in paediatric and adult patients?
• How to promote the best transition?
• Have outcomes been measured?
• What are the “meeting points” before transition process?
• How do patients feel? (representation from patient associations)
08.30 – 08.45 Welcome speech
08.45 – 10.35 Session 1: Hepatology/Cystic fibrosis
08.45 – 09.05 Diagnostic difficulties, paediatric side: CF: Henkjan Verkade, Groningen, Netherland
09.05 – 09.25 Diagnosis of CF at later age: adult side: Aghemo Alessio, Milano, Italy
09.25 – 09.45 Gastrointestinal aspects of new therapies in CF: Michael Wilschanski, Jerusalem, Israel
09.45 – 10.05 Adult treatment options for metabolic liver disease: Martin Wagner, Graz, Austria
10.05 – 10.35 Discussion
10.35 – 11.05 Coffee break
11.05 – 12.55 Session 2: Pancreas
11.05 – 11.25 Paediatric diagnosis of acute and chronic pancreatitis: Andrea Párniczky, Budapest, Hungary
11.25 – 11.45 Transitional meeting points in pancreatitis, role of ERCP: Péter Hegyi, Pécs, Hungary
11.45 – 12.05 Pediatric treatment for chronic pancreatitis. Is there transition for chronic pancreatitis?: Grzegorz Oracz, Warsow, Poland
12.05 – 12.25 Long-term effect of different type of genetic pancreatitis: Miklós Sahin-Tóth, Boston, USA
12.25 – 12.55 Discussion
12.55 – 13.55 Lunch
13.55 – 15.45 Session 3: IBD
13.55 – 14.15 Pediatric-adult transition clinic: the Dutch experience: Hankje Escher, Rotterdam, Netherland
14.15 – 14.35 Difference of Paediatric- and Adult diagnosis of IBD: Katalin Mueller, Budapest, Hungary
14.35 – 14.55 Exclusive enteral nutrition (EEN): success and pitfalls: Gábor Veres, Budapest, Hungary
14.55 – 15.15 Can be effective EEN for adult patients with IBD? Role of transition: Peter Lakatos, Quebec, Canada
15.15 – 15.45 Discussion
15.45-16.15 Coffee Break
16.15-18.00 Case Presentations with interactive discussion
08.30 – 10.20 Session 4: Celiac disease
08.30 – 08.50 Pitfalls of paediatric diagnosis of celiac disease: Jernej Dolinsek, Maribor, Slovenia
08.50 – 09.10 When can we skip upper endoscopy and histology in patients with celiac disease? Heinz Hammer, Graz, Austria
09.10 – 09.30 Pediatric treatment: what amount of gluten is dangerous for patients with celiac disease? Luisa Mearin, Leiden, Netherlands
09.30 – 09.50 Does effective follow-up of adult patients with celiac disease exist? Gianenrico Rizzatti, Rome, Italy
09.50 – 10.20 Discussion
10.20 – 10.50 Coffee break
10.50 – 12.40 Session 5: Eosinophilic esophagitis (EE)
10.50 – 11.10 Pediatric diagnosis of EoE. Pathomechanism in the process of EoE. Jorge Amil Dias, Porto, Portugal
11.10 – 11.30 Adult diagnosis of EoE. Is fibrosis reversible? Andreas Eherer, Graz, Austria
11.30 – 11.50 Pediatric treatment of EoE: role of PPI and steroid. Six foods or less are effective in EoE? Rok Orel, Ljubljana, Slovenia
11.50 – 12.10 Role of transition in patients with EoE: Ulrike von Arnim, Magdeburg, Germany
12.10 – 12.40 Discussion
12.40 – 13.40 Lunch
13.40 – 15.10 Case presentation with interactive discussion